Jessica Alderman Zeaske has left her position as director of healthcare investments at GE Ventures, power and industrial equipment producer General Electric’s corporate venturing fund.
Echo Health Ventures, a US-based joint investment venture formed by health services provider Cambia Health and health insurer Blue Cross and Blue Shield of North Carolina’s Mosaic Health Solutions unit, hired Zeaske as a partner.
Zeaske told Global Corporate Venturing: “Echo Health Ventures was launched [with] the belief that, given the significant market opportunity and substantial, long-term industry need, strategic investors have an obligation to rethink our investment models and collectively raise our game.
“The depth of commitment to changing the industry as well as the healthcare market was one key factor drawing me to Echo.”
In her GE Ventures role, Zeaske worked with and took board seats at two portfolio companies – data aggregation and analytics technology developer Arcadia and health analytics marketplace Apervita – both of which addressed data issues in the healthcare industry in novel ways, she said.
Prior to joining GE Ventures, Zeaske had been a principal at healthcare-focused venture capital firm Lemhi Ventures for more than eight years.
Regarding her new job, Zeaske said: “As a partner on the strategic investment team, one of my main goals for 2019 is to grow Echo’s pipeline of intriguing companies.
“With Echo being a stage-agnostic investor, and with the innovative focus of our parent organisations, this a challenge I am looking forward to. I am excited to meet our portfolio companies and hear their fresh ideas for transforming the healthcare system.”
Photo of Jessica Zeaske courtesy of Health 2.0.
